Skip to main content
MD

MindfulGarden Digital Health

MindfulGarden is a clinically validated biofeedback platform that utilizes affective biofeedback technology to manage agitation associated with hospital-acquired delirium, reducing the reliance on antipsychotic medications. By translating patient-generated distress signals into engaging nature-based visualizations and sounds, the platform aims to de-escalate adverse behaviors and improve health outcomes in critical care settings.

Vancouver, CanadaFounded 20174100+ followers
Updated 20 months ago

Funding

$454.9K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

AI
Funding rounds are not available yet.

Founders

Product

Problem

Hospital-acquired delirium is a common and costly medical emergency, affecting a significant percentage of patients in critical care and hospital-wide, leading to agitation, disorientation, increased mortality, and long-term cognitive decline. Traditional management relies on antipsychotics and restraints, which have shown devastating short and long-term implications.

Solution

MindfulGarden offers a clinically validated, non-pharmacological biofeedback platform designed to manage agitation associated with hospital-acquired delirium. The platform uses a game engine to translate patient-generated distress signals into gently moving nature-based visualizations and sounds, aiming to distract, engage, and de-escalate adverse behaviors. By harnessing biometrics to influence bio-state, MindfulGarden helps patients return to homeostasis, reducing the reliance on antipsychotic medications and restraints. The platform is independent of hospital IT, does not collect personal health information, and is designed for rapid deployment and ease of use.

Target Audience

The primary target audience includes hospitals and critical care facilities seeking non-pharmacological solutions for managing delirium, as well as clinicians looking to reduce reliance on antipsychotics and improve patient outcomes.

Features

  • Affective biofeedback technology that responds to patient-generated distress signals.
  • Nature-based visualizations and sounds that level up or down as the patient calms.
  • Clinically validated to reduce the use of PRN antipsychotic drugs and rapidly de-escalate agitation.
  • Independent of hospital IT systems.
  • Does not collect any personal health information.
  • Training takes only minutes.
  • Easily deployed at the bedside.
This profile is AI-generated and may contain inaccuracies.